Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

1281 – Increased Knowledge and Use of Doxycycline Postexposure Prophylaxis in King County, Washington

Background Following evidence of doxycycline postexposure prophylaxis (doxyPEP) efficacy to prevent chlamydia, gonorrhea and syphilis among men and transgender women who have sex with men, Public Health – Seattle & King County (PHSKC) released provider guidance in June 2023. We utilized data from PHSKC’s annual Pride Survey to assess changes in knowledge and self-reported doxyPEP…

1239 – Syphilis Screening in Hospitalized People With HIV: A Key Strategy to Tackle HIV and STI Epidemics

Background Active sexually transmitted infections (STI) elevate the risk of HIV acquisition, highlighting the need for timely diagnosis and treatment to address the intertwined HIV/STI epidemics. Latin America bears a disproportionate burden of STIs, with sexual and gender minorities most affected. In recent years, Brazil has experienced a concerning rise in acquired/congenital syphilis cases, particularly…

1258 – STAR: A Prospective Cohort of Women of Reproductive Age With and Without HIV in the Southern US

Background Nearly 25% of people living with HIV in the US are women, most of whom are racial/ethnic minorities living in the south. In 2022, people assigned female sex at birth accounted for 18% of the almost 38,000 incident HIV diagnoses. Of those, Black/African Americans age >=13 accounted for 50%, and 20% were Hispanic/Latina. Minority…

1279 – Factors Influencing Doxy-PEP Awareness Among Sexual/Gender Minorities: A Web-Based Survey in Brazil

Background Sexual and gender minorities (SGM) face a disproportionate burden of sexually transmitted infections (STIs) worldwide, particularly in Latin America. While doxycycline post-exposure prophylaxis (doxy-PEP) is recommended in some countries to prevent bacterial STIs, no official guidelines or implementation studies have been conducted in any country of the Global South. This study aims to identify…

1284 – Antimicrobial Consumption Among Users of Doxycycline Postexposure Prophylaxis in Milan, Italy

Background Aim is to evaluate the changes in antimicrobial consumption of ceftriaxone, benzylpenicillin and doxycycline for the treatment of bacterial sexually transmitted infections (bSTIs), after the prescription of doxycycline post-exposure prophylaxis (DoxyPEP) among men who have sex with men (MSM). Methods Retrospective study of MSM in care for HIV or HIV pre-exposure prophylaxis (PrEP) at…

1278 – Acceptability of Doxycycline as Post-Exposure Prophylaxis in Southeastern Louisiana

Background Louisiana ranks first in the nation for chlamydia incidence and third for gonorrhea, necessitating effective prevention strategies for sexually transmitted infections (STIs). Doxycycline post-exposure prophylaxis (doxy PEP) has emerged as a promising prevention strategy, but its success relies on acceptability among healthcare providers and clients. In particular, it is important to understand acceptability of…

1275 – Postexposure Prophylaxis With Doxycycline (Doxy PEP) in a Cohort of High-Risk MSM: The PRIDOX Study

Background Clinical trials have shown high efficacy of doxycycline as STI preventive strategy, but real-world data are limited. We aimed to assess the impact of DoxyPEP on Chlamydia trachomatis (CT), Neisseria gonorrhoeae(NG) and syphilis (SPL) incidence in a high-risk MSM cohort in a real-world setting. Methods PrEP users at our clinic, meeting high STI risk…

1276 – Doxycycline Post-Exposure Prophylaxis Continuum of Care Among MSM in Philadelphia, 2023

Background Doxycycline post-exposure prophylaxis (Doxy-PEP) is an effective tool for reducing bacterial sexually transmitted infection (STI) incidence among men who have sex with men (MSM). We sought to understand current rates of bacterial STIs (gonorrhea, chlamydia, syphilis) among MSM and generate Philadelphia’s first doxy-PEP continuum among MSM. Methods We used 2023 National HIV Behavioral Surveillance…

1256 – Multipurpose Vaginal Rings: Preferences From a National Discrete Choice Survey With US Women

Background Women worldwide need and want multipurpose prevention technologies (MPTs) to meet their varied sexual-reproductive health needs. Most MPTs in development are vaginal rings. We assessed US women’s preferences re: specific ring attributes, to optimize a nonhormonal MPT ring in development to prevent pregnancy, HIV, other sexually transmitted infections (STIs), and bacterial vaginosis (BV). Methods We conducted a…

1246 – Temporal Changes in Syphilis Prevalence and Population Characteristics Among MSM in India

Background Men who have sex with men (MSM) are at higher risk of syphilis infection compared to heterosexual men. Since 2018, syphilis prevalence has been increasing in high income countries, with limited data from low- and middle-income countries. We previously observed a 3-fold increase in syphilis prevalence between 2012 and 2017 among MSM in India.…